Sichuan Huiyu Pharmaceutical Co., Ltd.
SHH: 688553.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Zhao Ding
- Employees
- 1,382
- Headquarters
- Neijiang, China
- IPO year
- 2021
- Market cap
- CN¥8.6B
- Website
- https://www.huiyupharma.com
Loading 688553…
Loading profile data…Frequently asked questions about 688553
What does Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS) do?
Sichuan Huiyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of anti-tumor and injection drugs. It provides products in oncology and related fields, and other areas. The company was founded in 2010 and is headquartered in Neijiang, China.
Where does 688553.SS trade?
Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS) trades on the Shanghai Stock Exchange.
What sector is 688553.SS in?
Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Sichuan Huiyu Pharmaceutical Co., Ltd.?
Zhao Ding is the chief executive officer of Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS).
Where is Sichuan Huiyu Pharmaceutical Co., Ltd. headquartered?
Sichuan Huiyu Pharmaceutical Co., Ltd. is headquartered in China.
Does 688553.SS pay a dividend?
Yes — Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS) paid a trailing twelve-month dividend of CNY 0.46 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688553.SS go public?
Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS) completed its initial public offering in 2021.